valsartan has been researched along with cgp 42112a in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubey, RK; Flammer, J; Lüscher, TF | 1 |
| Cao, Z; Casley, D; Cooper, ME; Cox, A; Dean, R; Forbes, JM; Gilbert, RE; Kelly, DJ; Martinello, P | 1 |
| Carey, RM; Howell, NL; Jin, XH; Siragy, HM | 1 |
| Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Nahmias, C; Tomochika, H; Tsukuda, K | 1 |
| Chen, H; Hu, X; Jiang, Z; Li, J; Liu, X; Steinhoff, G; Wang, L; Xu, Y; Yu, H; Zhang, Z | 1 |
5 other study(ies) available for valsartan and cgp 42112a
| Article | Year |
|---|---|
Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Count; Cell Division; Cell Movement; Cells, Cultured; Ciliary Arteries; DNA; DNA Replication; Dose-Response Relationship, Drug; Drug Combinations; Insulin; Muscle, Smooth, Vascular; Oligopeptides; Swine; Tetrazoles; Valine; Valsartan | 1998 |
Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.
Topics: Age Factors; Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Autoradiography; Blood Pressure; Cell Division; Gene Expression; Guanosine 5'-O-(3-Thiotriphosphate); Imidazoles; In Situ Nick-End Labeling; Iodine Radioisotopes; Kidney; Male; Oligopeptides; Organ Size; Osteopontin; Proliferating Cell Nuclear Antigen; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Sialoglycoproteins; Tetrazoles; Valine; Valsartan | 2000 |
Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure Determination; Diet, Sodium-Restricted; Hypotension; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan; Vasodilation | 2001 |
Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Carrier Proteins; Cell Differentiation; Cell Nucleus; Cells, Cultured; DNA Repair; Imidazoles; Inhibitor of Differentiation Protein 1; Ligases; Mice; Nerve Tissue Proteins; Neurites; Neurons; Oligopeptides; Protein Phosphatase 1; Protein Transport; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Signal Transduction; Synapses; Tetrazoles; Transcriptional Activation; Tumor Suppressor Proteins; Valine; Valsartan; Vanadates | 2007 |
Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair.
Topics: Angiotensin II; Animals; Apoptosis; Bone Marrow Cells; Cell Transplantation; Coculture Techniques; Echocardiography; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Inflammation; Leukocytes, Mononuclear; Male; Myocardial Infarction; Myocytes, Cardiac; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Stem Cell Transplantation; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2013 |